With the pending Opioid Awareness Day on the Hill
approaching on Feb. 21, it’s a good reminder to Minnesota prescribers that they need to be registered with the state’s Prescription Monitoring Program (PMP) by July 1, 2017, as mandated by state law.
The MMA strongly encourages all physicians with a DEA number to register as soon as possible and to use the PMP as a tool to ensure proper use of narcotics.
The registration requirement
for prescribers became effective Aug. 1, 2016, following passage of legislation carried by Rep. Dave Baker (R-Wilmar) and Sen. Julie Rosen (R-Vernon Center). According to data from the PMP, since this requirement went into place through December 2016, there have been nearly 3,000 more prescribers registered with the PMP. This includes MDs and DOs.
The MMA supports attendance at Opioid Awareness Day as well as its own Day at the Capitol
on Feb. 15. Addressing the opioid epidemic in Minnesota is one of the MMA’s top legislative priorities this session.
The MMA backs efforts to make the PMP easier to use, specifically by advocating for funding to integrate the PMP with electronic health records. The MMA also supports efforts to allow greater access to treatment, such as removing prior authorization requirements for buprenorphine, naltrexone and naloxone.
The MMA continues to offer education programs
for prescribers designed to provide information on topics related to pain management, opioid prescribing and addiction. These programs have been created in partnership with the Steve Rummler Hope Foundation and the University of Minnesota Medical School.